Skip to main content
. 2020 Dec 8;12:12623–12633. doi: 10.2147/CMAR.S276316

Figure 1.

Figure 1

Expression of miR-613 in breast cancer tissues and cell lines. (A) qRT-PCR analysis of miR-613 in 132 cases of breast cancer samples and adjacent non-cancer tissues. (B) The expression of miR-613 in each subtype of breast cancer, including Luminal A (75 cases), Luminal B (24 cases), HER2 (9 cases) and TNBC (24 cases). (C) The expression of miR-613 in cell lines. ***p<0.001.